Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Asahi Kasei obtains exclusive rights to Xiaflex for two indications in Japan

March 23, 2011

Tesaro acquires rights to Amgen's anaplastic lymphoma kinase program

March 23, 2011

Seattle Genetics forms antibody-drug conjugate collaboration with Abbott

March 23, 2011

Alzheimer's Drug Discovery Foundation supports ADispell's neuroprotective drug research

March 23, 2011

Karo Bio and Zydus Cadila extend glucocorticoid research collaboration

March 23, 2011

Septodont acquires local anesthesia reversal agent OraVerse from Novalar

March 21, 2011

KineMed extends collaboration with Bristol-Myers Squibb for Alzheimer's disease

March 21, 2011

Lonza and Athera sign development and manufacturing agreement for PC-mAb

March 21, 2011

Nerviano enters into oncology license agreement with Novartis

March 21, 2011

Anacor and Medicines for Malaria Venture agree to jointly develop AN-3661

March 18, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.